Advestra advises Novartis on its USD 6.0 billion notes

Novartis successfully placed notes in the aggregate principal amount of USD 6.0 billion in seven tranches of which six were fixed rate notes while one tranche were floating rate notes. The fix rate notes were issued in the principal amount of USD 700 million 3.9% due 2028, USD 1,750 million 4.1% due 2030, USD 925 million 4.3% due 2032, USD 925 million 4.6% due 2035, USD 350 million 5.2% due 2045 and USD 550 million 5.3% due 2055. The floating rate notes were issued in the aggregate principal amount of USD 800 million and will be due 2028.

The notes were issued by Novartis Capital Corporation and guaranteed by Novartis AG.

Advestra acted as Swiss legal counsel to Novartis. The team included Annette Weber, Thomas Reutter and Mariëlle van Nimwegen (all Capital Markets) as well as Céline Martin (Tax).